The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery
Open accessAbstract
Recent progresses in the field of Induced Pluripotent Stem Cells (iPSCs) have opened up many gateways for the research in therapeutics. iPSCs are the cells which are reprogrammed from somatic cells using different transcription factors. iPSCs possess unique properties of self renewal and differentiation to many types of cell lineage. Hence could replace the use of embryonic stem cells (ESC), and may overcome the various ethical issues regarding the use of embryos in research and clinics. Overwhelming responses prompted worldwide by a large number of researchers about the use of iPSCs evoked a large number of peple to establish more authentic methods for iPSC generation. This would require understanding the underlying mechanism in a detailed manner. There have been a large number of reports showing potential role of different molecules as putative regulators of iPSC generating methods. The molecular mechanisms that play role in reprogramming to generate iPSCs from different types of somatic cell sources involves a plethora of molecules including miRNAs, DNA modifying agents (viz. DNA methyl transferases), NANOG, etc. While promising a number of important roles in various clinical/research studies, iPSCs could also be of great use in studying molecular mechanism of many diseases. There are various diseases that have been modeled by uing iPSCs for better understanding of their etiology which maybe further utilized for developing putative treatments for these diseases. In addition, iPSCs are used for the production of patient-specific cells which can be transplanted to the site of injury or the site of tissue degeneration due to various disease conditions. The use of iPSCs may eliminate the chances of immune rejection as patient specific cells may be used for transplantation in various engraftment processes. Moreover, iPSC technology has been employed in various diseases for disease modeling and gene therapy. The technique offers benefits over other similar techniques such as animal models. Many toxic compounds (different chemical compounds, pharmaceutical drugs, other hazardous chemicals, or environmental conditions) which are encountered by humans and newly designed drugs may be evaluated for toxicity and effects by using iPSCs. Thus, the applications of iPSCs in regenerative medicine, disease modeling, and drug discovery are enormous and should be explored in a more comprehensive manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Establishment in culture of pluripotential cells from mouse embryos
Evans, M. J., & Kaufman, M. H. (1981) · Nature · doi:10.1038/292154a0 · Cited by 8,607
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells1
Till, J. E., & McCulloch, E. A. (2011) · Radiation Research · doi:10.1667/rrxx28.1 · Cited by 4,036
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells
Till, J. E., & McCulloch, E. A. (1961) · Radiation Research · doi:10.2307/3570892 · Cited by 3,708
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Induced pluripotent stem cells generated without viral integration
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423
FUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt.1502 · Cited by 1,341
Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
Genetic engineering of human pluripotent cells using TALE nucleases
Hockemeyer, D., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., Cost, G. J., Zhang, L., Santiago, Y., Miller, J. C., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1927 · Cited by 1,135
The Developmental Capacity of Nuclei taken from Intestinal Epithelium Cells of Feeding Tadpoles
Gurdon, J. B. (1962) · Development · doi:10.1242/dev.10.4.622 · Cited by 1,083
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative
Initiative, T. I. S. C. (2007) · Nature Biotechnology · doi:10.1038/nbt1318 · Cited by 1,073
Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver, R. C., Katibah, G. E., Amora, R., Boydston, E. A., Zeitler, B., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1562 · Cited by 1,056
Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.004 · Cited by 902
Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells
Tada, M., Takahama, Y., Abe, K., Nakatsuji, N., & Tada, T. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00459-6 · Cited by 889
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs
Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M., Tomishima, M. J., Fasano, C. A., Ganat, Y. M., Menon, J., Shimizu, F., Viale, A., et al. (2009) · Nature · doi:10.1038/nature08320 · Cited by 867
Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse
Stadtfeld, M., Maherali, N., Breault, D. T., & Hochedlinger, K. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.02.001 · Cited by 823
Sequential Expression of Pluripotency Markers during Direct Reprogramming of Mouse Somatic Cells
Brambrink, T., Foreman, R., Welstead, G. G., Lengner, C. J., Wernig, M., Suh, H., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.004 · Cited by 821
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency
Hanna, J., Markoulaki, S., Schorderet, P., Carey, B. W., Beard, C., Wernig, M., Creyghton, M. P., Steine, E. J., Cassady, J. P., Foreman, R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.028 · Cited by 814
Hochedlinger, K., Yamada, Y., Beard, C., & Jaenisch, R. (2005) · Cell · doi:10.1016/j.cell.2005.02.018 · Cited by 747
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schüle, B., Dolmetsch, R. E., Langston, W., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.013 · Cited by 745
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Carvajal-Vergara, X., Sevilla, A., D’Souza, S. L., Ang, Y.-S., Schaniel, C., Lee, D.-F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R., et al. (2010) · Nature · doi:10.1038/nature09005 · Cited by 690
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E. (2011) · Nature · doi:10.1038/nature09855 · Cited by 677
A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells
Shi, Y., Tae Do, J., Desponts, C., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.011 · Cited by 671
Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon
Yusa, K., Rad, R., Takeda, J., & Bradley, A. (2009) · Nature Methods · doi:10.1038/nmeth.1323 · Cited by 620
Generation of human induced pluripotent stem cells from urine samples
Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., Wang, Y., Zhang, Y., Zhuang, Q., Li, Y., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.115 · Cited by 614
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells
Rashid, S. T., Corbineau, S., Hannan, N., Marciniak, S. J., Miranda, E., Alexander, G., Huang-Doran, I., Griffin, J., Ahrlund-Richter, L., Skepper, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43122 · Cited by 606
Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure.
Kerns, W., Pavkov, K. L., Donofrio, D. J., Gralla, E. J., & Swenberg, J. A. (1983) · PubMed · Cited by 586
Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.003 · Cited by 584
Direct reprogramming of human neural stem cells by OCT4
Kim, J. B., Greber, B., Araúzo-Bravo, M. J., Meyer, J., Park, K. I., Zaehres, H., & Schöler, H. R. (2009) · Nature · doi:10.1038/nature08436 · Cited by 577
Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome
Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., Panopoulos, A. D., Suzuki, K., Kurian, L., Walsh, C., et al. (2011) · Nature · doi:10.1038/nature09879 · Cited by 575
Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y., Lin, T., Hao, E., Hayek, A., Deng, H., & Ding, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.014 · Cited by 567
A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells
Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.08.003 · Cited by 563
Nori, S., Okada, Y., Yasuda, A., Tsuji, O., Takahashi, Y., Kobayashi, Y., Fujiyoshi, K., Koike, M., Uchiyama, Y., Ikeda, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108077108 · Cited by 545
Parkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486
Generation of Induced Pluripotent Stem Cells from Human Cord Blood
Haase, A., Olmer, R., Schwanke, K., Wunderlich, S., Merkert, S., Hess, C., Zweigerdt, R., Gruh, I., Meyer, J., Wagner, S., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.08.021 · Cited by 481
Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb
Feng, B., Jiang, J., Kraus, P., Ng, J.-H., Heng, J.-C. D., Chan, Y.-S., Yaw, L.-P., Zhang, W., Loh, Y.-H., Han, J., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1827 · Cited by 470
Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation
Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou, P., Song, Z., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.002 · Cited by 468
Generation of Functional Human Hepatic Endoderm From Human Induced Pluripotent Stem Cells
Sullivan, G. J., Hay, D. C., Park, I.-H., Fletcher, J., Hannoun, Z., Payne, C. M., Dalgetty, D., Black, J. R., Ross, J. A., Samuel, K., et al. (2010) · Hepatology · doi:10.1002/hep.23335 · Cited by 445
Wnt Signaling Promotes Reprogramming of Somatic Cells to Pluripotency
Marson, A., Foreman, R., Chevalier, B., Bilodeau, S., Kahn, M., Young, R. A., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.019 · Cited by 436
Somers, A., Jean, J.-C., Sommer, C. A., Omari, A., Ford, C. C., Mills, J. A., Ying, L., Sommer, A. G., Jean, J. M., Smith, B. W., et al. (2010) · Stem Cells · doi:10.1002/stem.495 · Cited by 423
Ye, Z., Zhan, H., Mali, P., Dowey, S., Williams, D. M., Jang, Y.-Y., Dang, C. V., Spivak, J. L., Moliterno, A. R., & Cheng, L. (2009) · Blood · doi:10.1182/blood-2009-04-217406 · Cited by 399
Guha, P., Morgan, J. W., Mostoslavsky, G., Rodrigues, N. P., & Boyd, A. S. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.01.006 · Cited by 368
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules
Li, Y., Zhang, Q., Yin, X., Yang, W., Du, Y., Hou, P., Ge, J., Liu, C., Zhang, W., Zhang, X., et al. (2011) · Cell Research · doi:10.1038/cr.2010.142 · Cited by 363
Utikal, J., Maherali, N., Kulalert, W., & Hochedlinger, K. (2009) · Journal of Cell Science · doi:10.1242/jcs.054783 · Cited by 346
Efficient generation of human iPSCs by a synthetic self-replicative RNA
Yoshioka, N., Gros, E., Li, H.-R., Kumar, S., Deacon, D. C., Maron, C., Muotri, A. R., Chi, N. C., Fu, X.-D., Yu, B. D., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.001 · Cited by 312
Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation
GHALEB, A. M., NANDAN, M. O., CHANCHEVALAP, S., DALTON, W. B., HISAMUDDIN, I. M., & YANG, V. W. (2005) · Cell Research · doi:10.1038/sj.cr.7290271 · Cited by 307
A clinical trial of creatine in ALS
Shefner, J. M., Cudkowicz, M. E., Schoenfeld, D., Conrad, T., Taft, J., Chilton, M., Urbinelli, L., Qureshi, M., Zhang, H., Pestronk, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142992.81995.f0 · Cited by 293
Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0346 · Cited by 291 · cited 1×
“…factors or to enhance the efficiency of reprogramming (Table 1) (Yu et al., 2007; Dimos et al., 2008; Hanna et al., 2008; Huangfu et al., 2008a,b; Mali et al., 2008; Marson et al., 2008; Mikkelsen et al., 2008; Park et al., 2008a; Shi et al., 2008a,b; Silva et al., 2008; Zhao et al., 2008; Zhou…”
BackgroundA randomized sequential trial of creatine in amyotrophic lateral sclerosis
Jan Groeneveld, G., Veldink, J. H., van der Tweel, I., Kalmijn, S., Beijer, C., de Visser, M., Wokke, J. H. J., Franssen, H., & Berg, L. H. V. D. (2003) · Annals of Neurology · doi:10.1002/ana.10554 · Cited by 283
PTPN11 mutations in LEOPARD syndrome
Legius, E., Schrander-Stumpel, C., Schollen, E., Pulles-Heintzberger, C., Gewillig, M., & Fryns, J.-P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.571 · Cited by 274
Desnuelle, C., Dib, M., Garrel, C., & Favier, A. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201300079364 · Cited by 264
Phenotypic correction of murine hemophilia A using an iPS cell-based therapy
Xu, D., Alipio, Z., Fink, L. M., Adcock, D. M., Yang, J., Ward, D. C., & Ma, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812090106 · Cited by 261
Batista, L. F. Z., Pech, M. F., Zhong, F. L., Nguyen, H. N., Xie, K. T., Zaug, A. J., Crary, S. M., Choi, J., Sebastiano, V., Cherry, A., et al. (2011) · Nature · doi:10.1038/nature10084 · Cited by 260
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
Kazuki, Y., Hiratsuka, M., Takiguchi, M., Osaki, M., Kajitani, N., Hoshiya, H., Hiramatsu, K., Yoshino, T., Kazuki, K., Ishihara, C., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.274 · Cited by 259
Generation of Endoderm-Derived Human Induced Pluripotent Stem Cells From Primary Hepatocytes
Liu, H., Ye, Z., Kim, Y., Sharkis, S., & Jang, Y.-Y. (2010) · Hepatology · doi:10.1002/hep.23626 · Cited by 250
Gonzalez, F., Barragan Monasterio, M., Tiscornia, G., Montserrat Pulido, N., Vassena, R., Batlle Morera, L., Rodriguez Piza, I., & Belmonte, J. C. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901471106 · Cited by 249
Choi, S. M., Kim, Y., Shim, J. S., Park, J. T., Wang, R.-H., Leach, S. D., Liu, J. O., Deng, C., Ye, Z., & Jang, Y.-Y. (2013) · Hepatology · doi:10.1002/hep.26237 · Cited by 248
In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins
Liu, H., Kim, Y., Sharkis, S., Marchionni, L., & Jang, Y.-Y. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002376 · Cited by 246
Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
Cao, F., Wagner, R. A., Wilson, K. D., Xie, X., Fu, J.-D., Drukker, M., Lee, A., Li, R. A., Gambhir, S. S., Weissman, I. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003474 · Cited by 234
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
Tanaka, T., Tohyama, S., Murata, M., Nomura, F., Kaneko, T., Chen, H., Hattori, F., Egashira, T., Seki, T., Ohno, Y., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.073 · Cited by 226
Suzuki, N., Yamazaki, S., Yamaguchi, T., Okabe, M., Masaki, H., Takaki, S., Otsu, M., & Nakauchi, H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.71 · Cited by 213
Ku, S., Soragni, E., Campau, E., Thomas, E. A., Altun, G., Laurent, L. C., Loring, J. F., Napierala, M., & Gottesfeld, J. M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.09.014 · Cited by 212
Tan, Q., Lui, P. P. Y., Rui, Y. F., & Wong, Y. M. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0362 · Cited by 207
Seiler, A., Visan, A., Buesen, R., Genschow, E., & Spielmann, H. (2004) · Reproductive Toxicology · doi:10.1016/j.reprotox.2003.10.015 · Cited by 189
Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells
Sugii, S., Kida, Y., Kawamura, T., Suzuki, J., Vassena, R., Yin, Y.-Q., Lutz, M. K., Berggren, W. T., Izpisúa Belmonte, J. C., & Evans, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910172106 · Cited by 179
Yoshida, Y., & Yamanaka, S. (2010) · Circulation · doi:10.1161/circulationaha.109.881433 · Cited by 172
Li, Y., Tsai, Y.-T., Hsu, C.-W., Erol, D., Yang, J., Wu, W.-H., Davis, R. J., Egli, D., & Tsang, S. H. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00242 · Cited by 166
A DNA Repair Complex Functions as an Oct4/Sox2 Coactivator in Embryonic Stem Cells
Fong, Y. W., Inouye, C., Yamaguchi, T., Cattoglio, C., Grubisic, I., & Tjian, R. (2011) · Cell · doi:10.1016/j.cell.2011.08.038 · Cited by 165
Yokoo, N., Baba, S., Kaichi, S., Niwa, A., Mima, T., Doi, H., Yamanaka, S., Nakahata, T., & Heike, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.052 · Cited by 165
Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease
Grizot, S., Smith, J. N. P., Daboussi, F., Prìeto, J., Redondo, P. N., Merino, N., Villate, M., Thomas, S., Lemaire, L., Montoya, G., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp548 · Cited by 162
Present state and future perspectives of using pluripotent stem cells in toxicology research
Wobus, A. M., & Löser, P. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0641-6 · Cited by 159
An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
Filareto, A., Parker, S., Darabi, R., Borges, L., Iacovino, M., Schaaf, T. M., Mayerhofer, T., Chamberlain, J. S., Ervasti, J. M., McIvor, R. S., et al. (2013) · Nature Communications · doi:10.1038/ncomms2550 · Cited by 156
Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells
Lim, W. F., Inoue-Yokoo, T., Tan, K. S., Lai, M. I., & Sugiyama, D. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt222 · Cited by 127
Farra, N., Zhang, W.-B., Pasceri, P., Eubanks, J. H., Salter, M. W., & Ellis, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.180 · Cited by 123
Nuclear transplantation: lessons from frogs and mice
Hochedlinger, K., & Jaenisch, R. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00380-0 · Cited by 123
Fong, H., Wang, C., Knoferle, J., Walker, D., Balestra, M. E., Tong, L. M., Leung, L., Ring, K. L., Seeley, W. W., Karydas, A., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.08.001 · Cited by 122
Lei, K. J., Chen, Y. T., Chen, H., Wong, L. J., Liu, J., McConkie‐Rosell, A., Hove, J. L. V., Ou, H. C., Yeh, N. J., & Pan, L. Y. (1995) · PubMed Central · Cited by 120
Engineering of Human Pluripotent Stem Cells by AAV-mediated Gene Targeting
Khan, I., Hirata, R. K., Wang, P.-R., Li, Y., Kho, J., Nelson, A., Huo, Y., Zavaljevski, M., Ware, C. B., & Russell, D. W. (2010) · Molecular Therapy · doi:10.1038/mt.2010.55 · Cited by 114
Yoshida, T., Ozawa, Y., Suzuki, K., Yuki, K., Ohyama, M., Akamatsu, W., Matsuzaki, Y., Shimmura, S., Mitani, K., Tsubota, K., et al. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-45 · Cited by 113
Suzuki, K., Mitsui, K., Aizawa, E., Hasegawa, K., Kawase, E., Yamagishi, T., Shimizu, Y., Suemori, H., Nakatsuji, N., & Mitani, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806976105 · Cited by 109
Gunaseeli, I., Doss, M. X., Antzelevitch, C. N., Hescheler, J., & Sachinidis, A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790514480 · Cited by 104
Human pluripotent stem cells in drug discovery and predictive toxicology
Laustriat, D., Gide, J., & Peschanski, M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381051 · Cited by 103
How does Fgf signaling from the isthmic organizer induce midbrain and cerebellum development?
Sato, T., Joyner, A. L., & Nakamura, H. (2004) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2004.00769.x · Cited by 96
Levenberg, S., Ferreira, L., Chen‐Konak, L., Kraehenbuehl, T. P., & Langer, R. (2010) · Nature Protocols · doi:10.1038/nprot.2010.31 · Cited by 95
Park, E. T., Gum, J. R., Kakar, S., Kwon, S. W., Deng, G., & Kim, Y. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.23225 · Cited by 94
Moad, M., Pal, D., Hepburn, A. C., Williamson, S. C., Wilson, L., Lako, M., Armstrong, L., Hayward, S. W., Franco, O. E., Cates, J., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.03.054 · Cited by 93
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives
Chun, Y. S., Byun, K., & Lee, B. (2011) · Anatomy & Cell Biology · doi:10.5115/acb.2011.44.4.245 · Cited by 93
Obstacles and Opportunities in New Drug Development
Kaitin, K. I. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100462 · Cited by 88
iPS cells to model CDKL5-related disorders
Amenduni, M., Filippis, R. D., Cheung, A. Y. L., Disciglio, V., Epistolato, M. C., Ariani, F., Mari, F., Mencarelli, M. A., Hayek, Y., Renieri, A., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.131 · Cited by 88
Generation of Induced Pluripotent Stem Cells from Human Kidney Mesangial Cells
Song, B., Niclis, J. C., Alikhan, M. A., Sakkal, S., Sylvain, A., Kerr, P. G., Laslett, A. L., Bernard, C. C. A., & Ricardo, S. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101022 · Cited by 86
Tulpule, A., Kelley, J. M., Lensch, M., McPherson, J., Park, I.-H., Hartung, O., Nakamura, T., Schlaeger, T., Shimamura, A., & Daley, G. Q. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.04.002 · Cited by 81
Dystrophin in frameshift deletion patients with Becker muscular dystrophy.
Gangopadhyay, S. B., Sherratt, T. G., Heckmatt, J. Z., Dubowitz, V., Miller, G., Shokeir, M. H. K., Ray, P. N., Strong, P. N., & Worton, R. G. (1992) · Europe PMC (PubMed Central) · Cited by 76
High-Efficient Generation of Induced Pluripotent Stem Cells from Human Astrocytes
Ruiz, S., Brennand, K., Panopoulos, A. D., Herrerias, A., Gage, F. H., & Izpisúa‐Belmonte, J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015526 · Cited by 76
Mcneish, J., Roach, M. L., Hambor, J., Mather, R., Weibley, L., Lazzaro, J., Gazard, J., Schwarz, J. A., Volkmann, R., Machacek, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098814 · Cited by 74
Direct Generation of Induced Pluripotent Stem Cells from Human Nonmobilized Blood
Kunisato, A., Wakatsuki, M., Shinba, H., Ota, T., Ishida, I., & Nagao, K. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0063 · Cited by 74
Jiang, Y., Cowley, S. A., Siler, U., Melguizo, D., Tilgner, K., Browne, C., Dewilton, A., Przyborski, S., Saretzki, G., James, W. S., et al. (2012) · Stem Cells · doi:10.1002/stem.1053 · Cited by 71
Modeling Huntington’s Disease with Induced Pluripotent Stem Cells
Kaye, J. A., & Finkbeiner, S. (2013) · Molecular and cellular neurosciences · doi:10.1016/j.mcn.2013.02.005 · Cited by 66
Zhang, G., Shang, B., Yang, P., Cao, Z., Pan, Y., & Zhou, Q. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0649 · Cited by 59
Hurtado‐Lorenzo, A., Millan, E., Gonzalez‐Nicolini, V., Suwelack, D., Castro, M. G., & Lowenstein, P. R. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.021 · Cited by 57
Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells
Lan, M. L., Acharya, M. M., Tran, K. K., Bahari-Kashani, J. N., Patel, N. H., Strnádel, J., Giedzinski, E., & Limoli, C. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050048 · Cited by 56
Microcell-mediated chromosome transfer (MMCT): small cells with huge potential
Doherty, A. M. O., & Fisher, E. (2003) · Mammalian Genome · doi:10.1007/s00335-003-4002-0 · Cited by 55
Chestkov, I. V., Vasilieva, E. A., Illarioshkin, S. N., Lagarkova, M. A., & Киселев, С. Л. (2014) · Acta Naturae · doi:10.32607/20758251-2014-6-1-54-60 · Cited by 47
c-Myc, Genomic Instability and Disease
Kuttler, F., & Mai, S. (2006) · KARGER eBooks · doi:10.1159/000092507 · Cited by 43
Modelling familial dysautonomia in human induced pluripotent stem cells
Lee, G., & Studer, L. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0026 · Cited by 38
The prospect of induced pluripotent stem cells for diabetes mellitus treatment
Soejitno, A., & Prayudi, P. K. A. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811420198 · Cited by 36
Wang, X.-M., Yik, W. Y., Zhang, P., Lu, W., Dranchak, P. K., Shibata, D., Steinberg, S. J., & Hacia, J. G. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt130 · Cited by 33
Human ESC vs. iPSC—Pros and Cons
Pappas, J. J., & Yang, P. C.-M. (2008) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-008-9032-2 · Cited by 31
Targeting Drug Transporters – Combining In Silico and In Vitro Approaches to Predict In Vivo
Bahadduri, P. M., Polli, J. E., Swaan, P. W., & Ekins, S. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-700-6_4 · Cited by 26
Induced Pluripotent Stem Cells Are Sensitive to DNA Damage
Zhang, M., Yang, C., Liu, H., & Sun, Y. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.006 · Cited by 20
Briggs, J., Mason, E. A., Ovchinnikov, D. A., Wells, C. A., & Wolvetang, E. J. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0117 · Cited by 20
Cited by
Synthetic alternatives to Matrigel
Aisenbrey, E. A., & Murphy, W. L. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-0199-8 · Cited by 1,016
Li, R., Hornberger, K., Dutton, J. R., & Hubel, A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00001 · Cited by 599
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity
Olova, N., Simpson, D. J., Marioni, R. E., & Chandra, T. (2019) · Aging Cell · doi:10.1111/acel.12877 · Cited by 190
Genetic disorders coupled to ROS deficiency
O’Neill, S., Brault, J., Stasia, M.-J., & Knaus, U. G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.009 · Cited by 164
Metadata
- Authors
- Singh, V. K., Kalsan, M., Kumar, N., Saini, A., & Chandra, R.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2015-02-02
- Volume
- 3
- Pages
- 2-2
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2081331532
- Cited by
- 416
- References
- 134
- FWCI
- 18.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.